Shanghai Jiao Tong University

Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Monday, April 1, 2024

WESTLAKE VILLAGE, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, reported fourth quarter and full year 2023 financial results and business updates.

Key Points: 
  • – $23.2 million in cash, cash equivalents and short-term investments –
    WESTLAKE VILLAGE, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, reported fourth quarter and full year 2023 financial results and business updates.
  • Currently, 21 sites have been activated to enroll patients with additional sites identified and in various stages of activation ( NCT05281471 ).
  • Genelux and our partner Newsoara co-sponsor the trial, which is being conducted by Newsoara in greater China.
  • Cash, cash equivalents and short-term investments were $23.2 million as of December 31, 2023 compared to $0.4 million on December 31, 2022.

Countdown to the Finals of the ASC24 Student Supercomputer Challenge!

Retrieved on: 
Tuesday, April 2, 2024

The focal point of the ASC24 finals will revolve around tackling cutting-edge scientific issues, such as advancing large language models (LLM), exploring Mars, and enhancing techniques for oil and gas exploitation.

Key Points: 
  • The focal point of the ASC24 finals will revolve around tackling cutting-edge scientific issues, such as advancing large language models (LLM), exploring Mars, and enhancing techniques for oil and gas exploitation.
  • Alongside the primary challenges, the finals will include a Group Competition aimed at fostering cross-team collaboration among students.
  • Numerous new teams are set to join the finals, with Shanghai University, Lanzhou University, and Southern University of Science and Technology among them.
  • The enthusiasm of these new contenders promises to elevate the competition, ensuring an intense battle until the very end.

Which lubricant brand is the strongest? The LubTop2023 Overall Evaluation List and Automobile Service Competitiveness Selection unveil the global honors.

Retrieved on: 
Tuesday, April 2, 2024

SHANGHAI, April 2, 2024 /PRNewswire/ -- On March 28, 2024, the much-anticipated "LubTop2023 China Lubricant Industry Annual Overall Evaluation List and Automobile Service Competitiveness Selection" (hereinafter referred to as the LubTop2023 Overall Evaluation List) was grandly unveiled and globally broadcast live from the Sheraton Shanghai Pudong Hotel.

Key Points: 
  • SHANGHAI, April 2, 2024 /PRNewswire/ -- On March 28, 2024, the much-anticipated "LubTop2023 China Lubricant Industry Annual Overall Evaluation List and Automobile Service Competitiveness Selection" (hereinafter referred to as the LubTop2023 Overall Evaluation List) was grandly unveiled and globally broadcast live from the Sheraton Shanghai Pudong Hotel.
  • The annual "LubTop Overall Evaluation List" and "ApexTire Tire Annual Excellence Awards," widely regarded as the "industry Oscars," attract global attention each year.
  • The "LubTop Overall Evaluation List" selection event is held annually and is now in its eleventh edition.
  • According to the organizing committee, the "LubTop2023 Overall Evaluation List" selection event adopts a brand core evaluation system based on five dimensions: innovation-driven, market win-win, user experience, industry leadership, and green development.

Which tire brand is the strongest? The global rankings are revealed in the ApexTire2023 Tire Annual Excellence Awards.

Retrieved on: 
Tuesday, April 2, 2024

The "ApexTire2023 China Tire Annual Excellence Awards and Automobile Service Competitiveness Selection," themed "New Quality, New Momentum" (hereinafter referred to as ApexTire2023), is initiated and organized by TireChina.net, with support from mainstream industry institutions and numerous media partners.

Key Points: 
  • The "ApexTire2023 China Tire Annual Excellence Awards and Automobile Service Competitiveness Selection," themed "New Quality, New Momentum" (hereinafter referred to as ApexTire2023), is initiated and organized by TireChina.net, with support from mainstream industry institutions and numerous media partners.
  • This event aimed to lead industry professionals to engage in deeper reflections on the industry and actively promote its healthy development.
  • The new quality productivity leads the tire industry onto a new track.
  • "ApexTire2023" aims to "establish industry benchmarks and inspire the future of the industry," guiding the direction of tire product and technological advancement.

Shanghai's Lujiazui adds 5 global asset management institutions

Retrieved on: 
Tuesday, March 5, 2024

Lujiazui has become an important cluster for global asset management institutions in China.

Key Points: 
  • Lujiazui has become an important cluster for global asset management institutions in China.
  • It now boasts about 80 percent of foreign-funded asset management institutions, 40 percent of foreign-funded corporate banks, nearly one-third of public fund management companies, and nearly one quarter of insurance asset management institutions of the total in the country, Xiao said.
  • More than 80 world-renowned financial institutions from 13 countries have established over 120 foreign asset management institutions in Lujiazui.
  • "Lujiazui is an important gathering place and business expansion place for global asset management institutions in China.

Shanghai's Lujiazui adds 5 global asset management institutions

Retrieved on: 
Tuesday, March 5, 2024

Lujiazui has become an important cluster for global asset management institutions in China.

Key Points: 
  • Lujiazui has become an important cluster for global asset management institutions in China.
  • It now boasts about 80 percent of foreign-funded asset management institutions, 40 percent of foreign-funded corporate banks, nearly one-third of public fund management companies, and nearly one quarter of insurance asset management institutions of the total in the country, Xiao said.
  • More than 80 world-renowned financial institutions from 13 countries have established over 120 foreign asset management institutions in Lujiazui.
  • "Lujiazui is an important gathering place and business expansion place for global asset management institutions in China.

SMARTKEM ANNOUNCES JOINT DEVELOPMENT AGREEMENT WITH TIANMA

Retrieved on: 
Tuesday, February 20, 2024

Smartkem Chairman and Chief Executive Officer, Ian Jenks comments, "This project is expected to demonstrate that Smartkem's unique technology can be used successfully to develop a new type of biochip using our OTFTs and Tianma's backplane.

Key Points: 
  • Smartkem Chairman and Chief Executive Officer, Ian Jenks comments, "This project is expected to demonstrate that Smartkem's unique technology can be used successfully to develop a new type of biochip using our OTFTs and Tianma's backplane.
  • The high charge mobility organic transistors of Smartkem at short transistor channel lengths, which represents its ability to drive current, is intended to surpass the performance of previous test results of the OTFT/oxide combination.
  • This is due to the substrate size difference, the largest Gen10.5 substrate being 135X larger in area than a 12" wafer.
  • SmartKem and SJTU recently published a joint paper in Nature Communications on their work to integrate OTFT with III-V semiconductor micro-LED wafers for high brightness displays.

SMARTKEM ANNOUNCES JOINT DEVELOPMENT AGREEMENT WITH TIANMA

Retrieved on: 
Tuesday, February 20, 2024

Smartkem Chairman and Chief Executive Officer, Ian Jenks comments, "This project is expected to demonstrate that Smartkem's unique technology can be used successfully to develop a new type of biochip using our OTFTs and Tianma's backplane.

Key Points: 
  • Smartkem Chairman and Chief Executive Officer, Ian Jenks comments, "This project is expected to demonstrate that Smartkem's unique technology can be used successfully to develop a new type of biochip using our OTFTs and Tianma's backplane.
  • The high charge mobility organic transistors of Smartkem at short transistor channel lengths, which represents its ability to drive current, is intended to surpass the performance of previous test results of the OTFT/oxide combination.
  • This is due to the substrate size difference, the largest Gen10.5 substrate being 135X larger in area than a 12" wafer.
  • SmartKem and SJTU recently published a joint paper in Nature Communications on their work to integrate OTFT with III-V semiconductor micro-LED wafers for high brightness displays.

ASC24 Student Supercomputer Challenge: Twenty-five University Teams Worldwide Advance to the Finals

Retrieved on: 
Wednesday, February 7, 2024

Over 300 universities worldwide participated, with twenty-five standout teams advancing to the finals.

Key Points: 
  • Over 300 universities worldwide participated, with twenty-five standout teams advancing to the finals.
  • Among the finalists are renowned institutions such as Huazhong University of Science and Technology, Peking University, the Chinese University of Hong Kong, National Tsing Hua University, Friedrich-Alexander-University Erlangen-Nuremberg, and the National University of Cordoba.
  • The ASC24 finals feature a lineup of traditional powerhouses, including Peking University - the champion of the 10th ASC onsite finals; the Chinese University of Hong Kong - the champion of the 10th ASC virtual finals; University of Science and Technology of China; Shanghai Jiao Tong University; and Friedrich-Alexander-University Erlangen-Nuremberg.
  • Additionally, there is great excitement surrounding the debut of teams from National University of Cordoba, Macau University of Science and Technology, and Southwest Petroleum University, marking their first appearance in the ASC finals this year.

Junshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer

Retrieved on: 
Thursday, January 18, 2024

NEOTORCH is a randomized, double-blind, placebo-controlled phase 3 trial evaluating the efficacy and safety of toripalimab in combination with perioperative platinum-based chemotherapy vs chemotherapy alone in patients with resectable stage II or III NSCLC.

Key Points: 
  • NEOTORCH is a randomized, double-blind, placebo-controlled phase 3 trial evaluating the efficacy and safety of toripalimab in combination with perioperative platinum-based chemotherapy vs chemotherapy alone in patients with resectable stage II or III NSCLC.
  • NEOTORCH is the world’s first phase III clinical study of a anti-PD-1 monoclonal antibody for NSCLC perioperative treatment (including neoadjuvant and adjuvant) with positive EFS results.
  • As a phase 3 clinical study of perioperative treatment, NEOTORCH enrolled the largest sample of resectable stage III NSCLC patients in China.
  • We anticipate that toripalimab will guide China’s perioperative lung cancer treatment into a new era.